RankingsPricing
  1. US-listed companies
  2. IONIS PHARMACEUTICALS INC
  3. Financials
  4. Net income margin (%)

IONIS PHARMACEUTICALS INCIONS

Market cap
$12.9B
P/E ratio
SummaryFinancials
Period EndNet income margin (%) YoY (%)
Dec 31, 2024-64.4+38.42%
Dec 31, 2023-46.5+1.27%
Dec 31, 2022-45.9+1201.41%
Dec 31, 2021-3.5-94.30%
Dec 31, 2020-61.9-329.07%
Dec 31, 201927-40.82%
Dec 31, 201845.6-3981.76%
Dec 31, 2017-1.2-95.29%
Dec 31, 2016-25-19.75%
Dec 31, 2015-31.1+70.94%
Dec 31, 2014-18.2-55.79%
Dec 31, 2013-41.2-35.83%
Dec 31, 2012-64.2-25.03%
Dec 31, 2011-85.6+51.56%
Dec 31, 2010-56.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)